SC Demonstration Grant
South Carolina Research Authority
About the Grant
The South Carolina Research Authority (SCRA) Member Companies may apply for a variety of non-dilutive grants, each with its own eligibility and review criteria.
The objective of a Small Business Demonstration Grant is to provide a valuable solution to a corporate partner and a significant growth opportunity for a small business by developing a new product, distribution channel, customer, market, etc. The grant is intended to offer a bridge for the small business to its next inflection point in development, while also supporting a monetary and/or in-kind match by a corporate partner into a project with the small business.
Demonstration Grants are limited typically to $50,000 with rare exceptions.
Notes
Note: This grant requires joining the SCRA as a member company. Memberhsip is free but requires an application review.
Member Companies deemed eligible to apply for SCRA Grant Funding opportunities will be invited by their assigned manager, who will advise them during the process. It is important to note that while acceptance as an SCRA Member Company qualifies you for consideration for funding, it does not guarantee approval.
Related Grants
Nebraska Innovation Fund Prototype Grants
Nebraska Dept. of Economic Development
The Nebraska Innovation Fund (NIF) Prototype Grant is a grant-matching program that provides up to $150,000 to support early-stage product development. Eligible businesses include Nebraska-based companies engaged in non-retail industries with fewer than 500 employees. Grant winners can use the funds for costs related to developing products, such as wages, prototype materials, and equipment.
Improved Stem Cell-Derived Islet Cells for Replacement Therapies
National Institutes of Health
This funding opportunity is designed to support research in understanding how to engineer intrinsic characteristics of stem cell-derived islet cell products that can result in improved cell replacement therapy outcomes. Unlike cadaveric human islets, stem cell-derived islet cell products are generated from well-defined and highly controlled cell bank sources. Their banking, manufacturing, and quality control processes can be used to instill optimized cell characteristics resulting in more resilient and durable graft viability and function. This funding opportunity aims to stimulate studies on targets and pathways amenable to such engineering approaches and to encourage preclinical testing and validation of such strategies.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.
Innovative Pilot Mental Health Services Research Not Involving Clinical Trials
National Institutes of Health
The purpose of this Notice of Funding Announcement (NOFO) is to encourage pilot research that is not an immediate precursor to testing a service intervention but is consistent with NIMH priorities for services research. While NIMH now requires use of an experimental therapeutics model for all intervention studies, there is recognition that some mission-relevant areas of services research do not involve clinical trials.
Newport News Façade Improvement Grant
City of Newport News
The objective of the Façade Improvement Grant (FIG) program is to restore, sustain, and improve commercial properties located within the City of Newport News. The FIG program provides matching grant funds, up to a maximum of $20,000, to assist with eligible façade improvements on properties citywide that are used for commercial, industrial, office or mixed-use purposes.